News

Article Feature

Dr. Sloan was quoted in an article from the University of Minnesota Clinical and Translational Science Institute, "Parents Leading Science Retreat Strengthens Connections Across Cohorts" on January 23, 2026.

Medical School Annual Report 2025

Lindsey Sloan gave an interview featured on the main page of the University of Minnesota Medical School Annual Report 2025. Watch the report.

UROP Award

Student Advisee Cambell Blackledge mentored by Dr. Sloan received the Undergraduate Research Opportunities Program (UROP) award for Spring 2026. Congratulations!

Randy Shaver Cancer Research and Community Fund Grant

The Randy Shaver Cancer Research & Community Fund has selected Dr. Lindsey Sloan's research study for a grant award of $40,000 in 2026.

Newcastle University and Xstrahl Preclinical Irradiation Meeting 2025

Lindsey Sloan gave a talk on November 25, 2025 in Newcastle, UK, "Translational Radiotherapy Paradigms in Pre-clinical Glioma Models".

Poster presentations and Neuro-Oncology published abstracts from SNO 2025

Lindsey Sloan presented, "Targeting a Unique Activation Receptor Complex to Treat Intracranial Breast Carcinoma" on November 19, 2025. Several abstracts were presented at SNO 2025 and published in the journal Neuro-Oncology.

• Brijal Desai, Clark Chen, Andrew Kopecky, Mark Rivard, Stuart Lee, M Sean Peach, John Wanebo, Toral Patel, Mohamed Khattab, David Piccioni, John Flyod, Simon Hanft, Akash Patel, Lewis Leng, Lindsey Sloan, Andrea Wasilewski, Vincent DiNapoli, Angela Richardson, Ondrej Choutka, Adam Robin, Catherine E Mercado, Huong Pham, Robert Ryan, Brian Williams, James Zhu, Xiaoran Zhang, Daniel Kim, Johnny Donovan, Sita Patel, Mike Garcia, Dave Brachman, RADT-65. SURGICALLY TARGETED RADIATION THERAPY (START) FOR RECURRENT MENINGIOMA: INITIAL REPORT ON A MULTI-INSTITUTIONAL PROSPECTIVE STUDY, Neuro-Oncology, Volume 27, Issue Supplement_5, November 2025, Page v107, https://doi.org/10.1093/neuonc/noaf201.0434

• Rupesh Kotecha, Stuart Lee, M Sean Peach, John Floyd, Toral Patel, Lewis Lang, Lindsey Sloan, Colette Shen, John Wanebo, Roukoz Chamoun, Adam Robin, Andrea Wasilewski, Kimberly Hoang, Angela Richardson, Simon Hanft, Ondrej Choutka, Akash Patel, Analiz Rodriguez, Michele Aizenberg, James Zhu, Daniel Kim, Sita Patel, Dave Brachman, Mike Garcia, RADT-51. SURGICALLY TARGETED RADIATION THERAPY (START) FOR PREVIOUSLY IRRADIATED RECURRENT BRAIN METASTASES: INITIAL REPORT FROM A MULTI-INSTITUTIONAL PROSPECTIVE STUDY, Neuro-Oncology, Volume 27, Issue Supplement_5, November 2025, Page v104, https://doi.org/10.1093/neuonc/noaf201.0420

• M Sean Peach, Susan M Woody, Bryce Pugh, Andrew W Ju, Stuart Lee, Lindsey Sloan, Adam Nowlan, David McCracken, Colette Shen, Andrea Wasilewski, John Wanebo, Kris Smith, John Floyd, Toral Patel, Vincent DiNapoli, Mohamed Khattab, Mitesh Shah, Angela Richardson, Simon Hanft, Ondrej Choutka, Catherine E Mercado, Devon H Haydon, Huong Pham, Robert Ryan, Akash Patel, Amir Lavaf, Mark Hoeprich, Parag Sevak, Lewis Leng, Harish Babu, Linda Chan, Xiaoran Zhang, Clark Chen, Kushal Shah, Jeffrey Beecher, Dave Brachman, RADT-74. SURGICALLY TARGETED RADIATION THERAPY FOR RECURRENT GRADE IV GLIOMAS: INITIAL RESULTS FROM A MULTICENTER PROSPECTIVE COHORT STUDY, Neuro-Oncology, Volume 27, Issue Supplement_5, November 2025, Pages v109–v110, https://doi.org/10.1093/neuonc/noaf201.0443

• Samuel Workman, Anne Li, Yurika Tarui, Sriya Pokala, I-Chia Liu, Lindsey Greenlund, Lindsey Sloan, Kristin Redmond, Lawrence Kleinberg, BIOM-92. MONOCYTE-LYMPHOCYTE IMMUNODYNAMICS PROGNOSTICATE SURVIVAL IN GBM PATIENTS TREATED WITH CHEMORADIATION, Neuro-Oncology, Volume 27, Issue Supplement_5, November 2025, Page v46, https://doi.org/10.1093/neuonc/noaf201.0180

• Sushant Puri, Lindsey Sloan, Sudipto Ganguly, Peng Huan, Lawrence Kleinberg, IMMU-75. Cytokine Kinetics During Radiation Therapy in Glioblastoma Predict Survival, Neuro-Oncology, Volume 27, Issue Supplement_5, November 2025, Page v220, https://doi.org/10.1093/neuonc/noaf201.0873

• Marissa Kaufman, Marnelle Anderson, Lydia Golden, Nicole Sando, Kyra Boorsma Bergerud, Suzanne Coleman, Caryn Martin, Elizabeth Bowser, David Sterling, Marie DiBona, Lawrence Kleinberg, David Largaespada, Jessica Lawrence, Mark Folkertsma, Garrett Fitzpatrick, Sara Alcorn, Jianling Yuan, Mayur Sharma, Matthew Hunt, Elizabeth Neil, Stephanie Terezakis, Lindsey Sloan, RBIO-19. Radiation-Mediated MDSC Immunodynamics in Recurrent High-Grade Glioma, Neuro-Oncology, Volume 27, Issue Supplement_5, November 2025, Page v394, https://doi.org/10.1093/neuonc/noaf201.1559

• Clara Ferreira, Brian Jang, Lindsey Sloan, Margaret Reynolds, David Sterling, Kathryn Dusenbery, Elizabeth Neil, Jessica Vadas, Clark Chen, SURG-89. GammaTile Brachytherapy for Reirradiation in Recurrent Glioblastoma: A Retrospective Single-Institution Case Series, Neuro-Oncology, Volume 27, Issue Supplement_5, November 2025, Page v414, https://doi.org/10.1093/neuonc/noaf201.1641

• Stuart Lee, M Sean Peach, John Wanebo, Kris Smith, Lindsey Sloan, Simon Hanft, Adam Nowlan, David McCracken, Mike Garcia, SURG-90. Rate of infection after craniotomy for brain tumor resection and permanent implantation of surgically targeted radiation therapy: initial report on the first 250 consecutive patients from a multi-institutional prospective study, Neuro-Oncology, Volume 27, Issue Supplement_5, November 2025, Pages v414–v415, https://doi.org/10.1093/neuonc/noaf201.1642

• Birra Taha, Luke Sabal, Yoichi Watanabe, Lindsey Sloan, Andrew Venteicher, IMG-55. Characteristics of large metastases to the brain treated with stereotactic radiosurgery at a single institution: a survey of 1355 lesions and their sites of origin, Neuro-Oncology, Volume 27, Issue Supplement_5, November 2025, Page v285, https://doi.org/10.1093/neuonc/noaf201.1134

• Birra Taha, Luke Sabal, Yoichi Watanabe, Lindsey Sloan, Andrew Venteicher, IMG-56. Primary tumor type influences anatomical destination in large metastases to the brain and shows a preference for the posterior fossa, Neuro-Oncology, Volume 27, Issue Supplement_5, November 2025, Page v286, https://doi.org/10.1093/neuonc/noaf201.1135

• Birra Taha, Luke Sabal, Yoichi Watanabe, Lindsey Sloan, Andrew Venteicher, IMG-57. A probabilistic atlas for the spatial distribution of CNS metastases in the posterior fossa based on primary site of origin, Neuro-Oncology, Volume 27, Issue Supplement_5, November 2025, Page v286, https://doi.org/10.1093/neuonc/noaf201.1136

• Birra Taha, Luke Sabal, Yoichi Watanabe, Lindsey Sloan, Andrew Venteicher, IMG-58. Radiomics can delineate lung cancer subtypes in metastatic lesions to the brain using magnetic resonance imaging, Neuro-Oncology, Volume 27, Issue Supplement_5, November 2025, Page v286, https://doi.org/10.1093/neuonc/noaf201.1137

High School Outreach - Discover STEM

Dr. Lindsey Sloan presented "Understanding Cancer Treatment Mathematics" with Dr. Kevin Leder as part of the Discover STEM program for high school students on August 15, 2025.

Poster Presentation at ESTRO 2025

Brian Jang presented, "Physical Dose and BED Correction to GammaTile Brachytherapy with External Radiation Planning" at ESTRO 2025 in Vienna, Austria on May 3.

MCC Symposium 2025

Subbu Mishra presented a poster, "Neutrophil-to-Lymphocyte Ratio Changes in Meningiomas after Radiotherapy" at the MCC Research Symposium on April 22, 2025.

Poster Presentation at ARS

Dr. Sloan presented a poster, "Incidence of Rapid Early Progression (REP) and Rapid Early Response (RER) in Patients with Newly Diagnosed Glioblastoma Undergoing Resection and Immediate Post Resection Brachytherapy on a Prospective Trial" at the ARS Conference in Seattle, Washington on April 3, 2025. She also served as moderator of "Education Session 7: Palliative Radiotherapy".

ARS 2025 Poster Presentation and Travel Award

Congrats to Alex Grosinger on recieving the ARS travel award to present the following poster:
Grosinger, A., Bedell, D., Golden, L., Sando, N., Lawrence, J., Alcorn, S. R., Moore, J., Venteicher, A., Terezakis, S. A., Chen, L., Sloan, L. (2025). More than Meets the Eye: The Intersection of Radiotherapy and Myeloid Cell Invasion.

Randy Shaver Cancer Research and Community Fund Grant

Dr. Lindsey Sloan was awared $25,000 for "Immune-Guided Radiotherapy for Patients with Brain Tumors" from the Randy Shaver Cancer and Community Fund in 2025.

Hardwood Heros Halftime Event

Dr. Lindsey Sloan took part in the Hardwood Heroes halftime game during the Minnesota Gophers men's basketball game vs. Washington on Feb 1. Cancer survivors along with doctors, nurses, researchers, and caregivers went head to head in a short game.

University of Minnesota Foundation Research Grant

Marissa Kaufman was awarded a University of Minnesota Foundation Research grant of $3000 for her research project from January - June 2025. Marissa will be working on this project in the Sloan Laboratory. Congratulations!

Clinical Trials Open

The three clinical trials Dr. Sloan is PI of are open as of December 2024.

Poster Presentation at SNO 2024

Kyra Boorsma Bergerud presented, "Radiation fraction size differentially affects myeloid-derived suppressor cell (MDSC) subsets in WHO grade 1 meningioma" at SNO, November 2024.

UROP Award

Anna Roovers was awarded an Undergraduate Research Opportunities Program award for her project, "Leveraging the SARRP for Pre-clinical Research: Early Results." She will complete research in Sloan Lab in the Fall sememster of 2024. Congratulations!

Vikings "Crucial Catch"

Dr. Lindsey Sloan particpated in the Minnesota Vikings Crucial Catch game on Sunday, October 20 along with other M Health Fairview cancer physicians and staff. Crucial Catch is the NFL's early cancer detection and risk initiative which has been running for 16 seasons and educates fans on the importance of taking their health into their own hands.

An Evening with the University of Minnesota's Brain Tumor Program

Click to see photos from the dinner hosted by the UMN Brain Tumor Program. Dr. Sloan attended this dinner held on May 29, 2024.

ResearcHERS Rising Star 2024

Lindsey Sloan was awarded the American Cancer Society's ResearcHERS "Rising Star" on May 20, 2024.

Neuro-Oncology Innovation Challenge 2024

Lindsey Sloan participated as a moderator during the Neuro-Oncology Innovation Challenge held in Minneapolis, Minnesota April 22-23, 2024.

Masonic Cancer Center MINI Research Symposium 2024

Lindsey Sloan spoke as part of the Career Development Panel at the Masonic Cancer Center MINI Research Symposium held April 16, 2024 in Minneapolis, MN.

University of Minnesota Foundation Research grant

Isabella Wedes was awarded a University of Minnesota Foundation Research grant of $3000 for her summer research project titled "Comparison of Myeloid-derived Suppressor Cells Immediately before and after a Fraction of Radiotherapy." Bella will be working on this project in the Sloan Laboratory this summer. Congratulations!

MSCO 2024 Spring Conference Poster Presentation and Award

Congrats to Subbu Mishra and the entire team for their poster award of $1500 at the Minnesota Society of Clinical Oncology (MSCO) Spring Conference! Poster details:
Mishra, S., Berkseth, M., Golden, L., Bergerud, K.B., Wieworka, J., Sando, N., Lawrence, J., Chen, L., Ozutemiz, C., Neil, E., Ganguly, S., Kleinberg, L.R., Dusenbery, K.E., Venteicher, A., Yuan, J., Terezakis, S.A., Sloan, L. (2024). Radiotherapy's Role in Modulating Immune Response in Meningioma.

Lindsey Sloan, MD, PhD named Principal Investigator of three clinical trials

• A Multicenter Observational Study of GammaTile Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms (GTM-101)
  

• A Phase 3 Randomized Controlled Trial of Post-Surgical Stereotactic Radiotherapy (SRT) versus Surgically Targeted Radiation Therapy (STaRT) with Gamma Tile for Treatment of Newly Diagnosed Metastatic Brain Tumors (GTM-102)
  

• Feasibility Study of Resection and GammaTile® Followed by Concomitant External Beam Radiation Therapy (EBRT) and Temozolomide (TMZ) and Adjuvant TMZ in Newly Diagnosed Glioblastoma (GBM) (GTM-103)

Poster Presentation at UMN Fall Undergraduate Research Symposium 2023

Congratulations to Kyra Boorsma Bergerud on her poster presentation "Differences in Conventionally Fractionated vs. Ablative Radiation Exposure on Immune Cell Composition and Activation in Meningioma".

Poster Presentations at ASTRO 2023

Congratulations to Matt Berkseth, who presented two posters from the Sloan Lab group at the 2023 ASTRO Annual Meeting! Poster details:

Lindsey Greenlund, Matt Berkseth, Ryan Shanley, Nicole Sando, Lydia Golden, Jennifer Wieworka, Kyra Boorsma Bergerud, Michael Olin, G. Elizabeth Pluhar, Susan Arnold, Jessica Lawrence, Andrew Venteicher, Clark Chen, Clara Ferreira, Elizabeth Neil, Kathryn Dusenbery, Sudipto Ganguly, Lawrence Kleinberg, Stephanie Terezakis, Lindsey Sloan. The Effects of Adjuvant Chemoradiotherapy (CRT) on Myeloid-derived Suppressor Cell (MDSC) Subsets in Glioblastoma (GBM). doi: 10.1016/j.ijrobp.2023.06.1148

Kelsey Wanhainen, Matt Berkseth, Nicole Sando, Lydia Golden, Amy Techam, Jenn Wieworka, Kyra Boorsma Bergerud, Peter Argenta, Andrea O'Shea, Colleen Rivard, Rahel Ghebre, Deanna Teoh, Margaret Reynolds, Stephanie Terezakis, Jianling Yuan, Lindsey Sloan. Effect of External Beam Radiation Therapy (EBRT) and Brachytherapy (BT) on Circulating MDSC Populations in Patients Treated Definitively for Cervical Cancer. doi:10.1016/j.ijrobp.2023.06.1864